Pfizer
UEI: MHBQULRMEEJ5
• CAGE: 86491
OVERVIEW
Name
Pfizer
Awardee Type
Parent
(16 children)
Website
Headquarters
New York, NY
United States
United States
Ownership
Publicly Traded (NYSE:PFE)
Calculating
FEDERAL AWARD ANALYSIS
Historical Federal Obligations Awarded to Pfizer
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
FEDERAL REGISTRATION
Legal Name
PFIZER INC
UEI
MHBQULRMEEJ5
Cage Code
86491
Primary NAICS
Purpose of Registration
Federal Contracts and Assistance
Date Established
June 2, 1942
Initial Registration
Jan. 30, 2002
Last Registration
Dec. 22, 2022
Registration Activation
Dec. 22, 2022
Registration Expiration
Dec. 20, 2023
Fiscal Year End
1231
Entity Structure
Corporate Entity (Not Tax Exempt)
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Publicly Traded
Manufacturer of Goods
Publicly Traded
State of Incorporation
DE
Country of Incorporation
USA
Reported NAICS
Physical Address
235, East 42nd Street
New York, 10017
New York, 10017
Mailing Address
235 East 42nd Street
Contract Strategy & Management Group -219-9-4
New York, NY 10017
USA
Contract Strategy & Management Group -219-9-4
New York, NY 10017
USA
Government Point of Contact
Manager, Government Contracts
Tina Dindyal
275 North Field Drive
Lake Forest, IL 60045
USA
Tina Dindyal
275 North Field Drive
Lake Forest, IL 60045
USA
Past Performance Point of Contact
Paul Hiley
235 East 42nd Street
Contract Strategy & Management
New York, NY 10017
USA
235 East 42nd Street
Contract Strategy & Management
New York, NY 10017
USA
ACTIVE GSA SCHEDULES
- Global Blood Therapeutics
- PoP: 7/14/20 - 7/14/25
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $83,336
- Array Biopharma
- PoP: 4/30/19 - 4/30/24
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Pfizer
- PoP: 10/31/14 - 6/30/23
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $4,160,132
- Hospira Worldwide
- PoP: 9/30/14 - 9/30/23
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $797,475
- Global Blood Therapeutics
- PoP: 3/3/20 - 7/15/20 (Ended)
- Meridian Medical Technologies
- PoP: 5/31/16 - 6/30/22 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $215,071